SIGA Technologies, Inc. is engaged in the development and commercialization of solutions for various unmet medical needs and biothreats. The Company's lead product is TPOXX, an orally administered antiviral drug that targets orthopoxviruses infections. TPOXX is a small-molecule drug delivered to the Strategic Stockpile under the Project BioShield Act of 2004 (Project BioShield). TPOXX is an investigational product that is not approved by the United States Food and Drug Administration (FDA) as a treatment of smallpox or any other indication. The Company relies on and uses third parties known as contract manufacturing organizations (CMOs) to procure commercial raw materials and supplies, and to manufacture TPOXX. The Company identified a lead pre-clinical drug candidate with activity against four serotypes of the virus and which has shown efficacy in a murine model of disease.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Biotechnology
- Sub-Industry: Biotechnology
- Symbol: NASDAQ:SIGA
- CUSIP: 82691710
- Web: www.siga.com/
- Market Cap: $244.22 million
- Outstanding Shares: 54,164,000
- 50 Day Moving Avg: $3.25
- 200 Day Moving Avg: $3.23
- 52 Week Range: $1.90 - $3.88
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 3.78
- P/E Growth: 0.00
- Annual Revenue: $18.92 million
- Price / Sales: 8.87
- Book Value: ($3.76) per share
- Price / Book: -0.82
- EBIDTA: ($19,310,000.00)
- Net Margins: -165.62%
- Return on Assets: -21.48%
- Average Volume: 37,219 shs.
- Short Ratio: 9.46
Frequently Asked Questions for SIGA Technologies (NASDAQ:SIGA)
What is SIGA Technologies' stock symbol?
SIGA Technologies trades on the NASDAQ under the ticker symbol "SIGA."
How were SIGA Technologies' earnings last quarter?
SIGA Technologies, Inc. (NASDAQ:SIGA) posted its quarterly earnings results on Thursday, May, 1st. The company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of $0.22 by $0.28. The firm earned $0.55 million during the quarter, compared to the consensus estimate of $26.50 million. View SIGA Technologies' Earnings History.
Who are some of SIGA Technologies' key competitors?
Some companies that are related to SIGA Technologies include Osiris Therapeutics (OSIR), VBI Vaccines (VBIV), Anavex Life Sciences Corp. (AVXL), Mirati Therapeutics (MRTX), XOMA Corporation (XOMA), ContraFect Corporation (CFRX), Aevi Genomic Medicine (GNMX), Trillium Therapeutics (TRIL), Ohr Pharmaceuticals (OHRP), Can Fite Biopharma Ltd (CANF), KaloBios Pharmaceuticals (KBIO), Mateon Therapeutics (MATN), Windtree Therapeutics (WINT), Affymax (AFFY), Cubist Pharmaceuticals (CBST), Dendreon (DNDN), DNIB Unwind (BIND) and Durata Therapeutics (DRTX).
Who are SIGA Technologies' key executives?
SIGA Technologies' management team includes the folowing people:
- Eric A. Rose M.D., Executive Chairman of the Board
- Phillip Louis Gomez III, Chief Executive Officer, Director
- Daniel J. Luckshire, Chief Financial Officer, Executive Vice President, Secretary
- Dennis E. Hruby Ph.D., Chief Scientific Officer, Vice President
- James J. Antal CPA, Independent Director
- Michael Jonathan Bayer, Independent Director
- Thomas E. Constance, Independent Director
- Jeffrey B. Kindler, Independent Director
- Joseph W. Marshall III, Independent Director
How do I buy SIGA Technologies stock?
Shares of SIGA Technologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is SIGA Technologies' stock price today?
MarketBeat Community Rating for SIGA Technologies (NASDAQ SIGA)MarketBeat's community ratings are surveys of what our community members think about SIGA Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of SIGA Technologies stock can currently be purchased for approximately $3.10.
Consensus Ratings for SIGA Technologies (NASDAQ:SIGA) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for SIGA Technologies (NASDAQ:SIGA)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for SIGA Technologies (NASDAQ:SIGA)Earnings History by Quarter for SIGA Technologies (NASDAQ SIGA)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/1/2014||Q1||$0.22||($0.06)||$26.50 million||$0.55 million||View||Listen|
|3/10/2014||Q413||($0.08)||$2.50 million||$0.90 million||View||N/A|
|3/6/2013||Q4 2012||($0.07)||($0.06)||$5.00 million||$2.50 million||View||N/A|
|11/5/2012||Q312||$0.11||($0.06)||$3.60 million||$2.30 million||View||N/A|
Earnings Estimates for SIGA Technologies (NASDAQ:SIGA)
Current Year EPS Consensus Estimate: $1.03 EPS
Next Year EPS Consensus Estimate: $0.82 EPS
Dividend History for SIGA Technologies (NASDAQ:SIGA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for SIGA Technologies (NASDAQ:SIGA)Insider Trades by Quarter for SIGA Technologies (NASDAQ:SIGA)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/7/2014||& Forbes Holdings I Macandrews||Director||Buy||199,727||$1.50||$299,590.50|| |
|9/26/2014||Bruce Slovin||Director||Sell||25,000||$1.35||$33,750.00|| |
|9/24/2014||& Forbes Holdings I Macandrews||Director||Buy||204,157||$1.34||$273,570.38|| |
|9/23/2014||& Forbes Holdings I Macandrews||Director||Buy||151,158||$1.33||$201,040.14|| |
|9/17/2013||Michael Bayer||Director||Buy||15,000||$3.58||$53,700.00|| |
|9/13/2013||Michael Bayer||Director||Sell||15,000||$3.55||$53,250.00|| |
|5/30/2013||Bruce Slovin||Director||Sell||15,000||$3.83||$57,450.00|| |
|5/24/2013||Joseph W Marshall III||Director||Buy||7,000||$3.59||$25,130.00|| |
Headline Trends for SIGA Technologies (NASDAQ:SIGA)
Latest Headlines for SIGA Technologies (NASDAQ:SIGA)
|SIGA Technologies (SIGA) Presents At Jefferies 2017 Global Healthcare Conference - Slideshow|
seekingalpha.com - June 12 at 7:17 PM
|SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017|
finance.yahoo.com - June 9 at 8:04 PM
|SIGA Technologies (SIGA) Given News Sentiment Score of 0.31|
www.americanbankingnews.com - April 26 at 8:00 PM
|Favorable Media Coverage Extremely Likely to Affect SIGA Technologies (SIGA) Stock Price|
www.americanbankingnews.com - April 22 at 8:31 AM
|SIGA Completes Enrollment and Dosing in Final Cohort of Phase I Study of IV Formulation of TPOXX® (tecovirimat) to Treat Smallpox|
finance.yahoo.com - April 20 at 8:13 AM
|SIGA TECHNOLOGIES INC Files SEC form 10-K, Annual Report|
biz.yahoo.com - March 7 at 7:42 PM
|Form 8-K SIGA TECHNOLOGIES INC For: Dec 22|
www.streetinsider.com - December 23 at 7:58 PM
|SIGA TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. o|
biz.yahoo.com - December 13 at 8:17 PM
|SIGA TECHNOLOGIES INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Bal|
biz.yahoo.com - November 18 at 7:03 PM
|SIGA Technologies (SIGA) Announces Completion of $35.3M Rights Offering|
www.streetinsider.com - November 16 at 7:45 PM
|SIGA Announces Successful Completion of Rights Offering; Funding of Loan; Completion of Payment of PharmAthene Obligation|
finance.yahoo.com - November 16 at 7:45 PM
|SIGA TECHNOLOGIES INC Financials|
finance.yahoo.com - November 9 at 7:30 PM
|SIGA TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report|
biz.yahoo.com - November 2 at 7:47 PM
|SIGA TECHNOLOGIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits|
biz.yahoo.com - October 21 at 7:21 PM
|SIGA TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Sec|
biz.yahoo.com - October 19 at 7:58 PM
|SIGA TECHNOLOGIES INC Files SEC form 8-K, Other Events|
biz.yahoo.com - October 6 at 7:01 PM
|SIGA Technologies (SIGA) Says Bankruptcy Court Approves Transaction to Pay PharmAthene Claim in Full|
www.streetinsider.com - September 22 at 6:58 PM
|SIGA TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial|
biz.yahoo.com - September 7 at 7:25 PM
|5:41 pm SIGA Technologies announces DSMB approval to complete subject enrollment in the final cohort of Phase III Study of TPOXX (tecovirimat); actions achieve critical BARDA milestone; company now eligible for $20.5 million payment|
finance.yahoo.com - August 8 at 7:37 PM
|SIGA TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principa|
biz.yahoo.com - August 2 at 7:45 PM
SIGA Technologies (SIGA) Chart for Tuesday, July, 25, 2017